person
Otilia B. P.
- Country
- Spain
- Department
- Internal Medicine department-Infectious diseases
Research Overview
assignment
2
Clinical Trials ·
- Efficacy and Safety of Islatravir and Ulonivirine Once Weekly versus Bictegravir, Emtricitabine, and Tenofovir Alafenamide Once Daily in Treatment-Naïve Adults with HIV-1
- A Phase 2b Randomized, Open-Label Active Controlled Study Evaluating the Safety and Efficacy of oral VH4524184 Coadministered with Emtricitabine and Tenofovir Alafenamide in Treatment Naïve Viremic Persons with HIV-1.( INNOVATE Study)
location_city
1
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
13
Sites with multiple studies
Has run more than one trial at 13 of 78 partner sites.
Specializations
Viral Hepatitis Research
This investigator specializes in the clinical management and treatment of chronic Hepatitis B virus (HBV) infection, with particular emphasis on innovative therapeutic approaches.
- Chronic HBV Management
- Antiviral Therapeutics
- Viral Load Monitoring
HIV Clinical Studies
The investigator focuses on HIV/HBV coinfection research, exploring treatment strategies for patients managing both conditions simultaneously.
- HIV/HBV Coinfection
- Antiretroviral Treatment
- Viral Response Assessment
Infectious Disease Management
Expertise extends to comprehensive infectious disease treatment with specific interest in dual viral infection management and therapeutic outcomes.
- Combination Therapy
- Treatment Response
- Long-term Disease Management
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.